baicalin has been researched along with Colitis, Ulcerative in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, K; Cong, W; Dou, Y; Gao, Y; Jia, D; Li, W; Li, Z; Ma, M; Wu, Z; Zhou, X | 1 |
| Li, L; Liang, Y; Peng, L; Wang, Z; Wu, K; Yan, Y; Zhang, G | 1 |
| Shen, H; Shen, ZF; Xu, LZ; Zhan, LB; Zhao, S; Zhu, L | 1 |
| Chen, J; Chen, Y; Huang, S; Li, Y; Luo, S; Luo, X; Wang, Q; Wang, X; Xu, B; Zhou, L | 1 |
| He, WX; Liu, D; Lu, JL; Xu, YJ; Yang, JY; Zhang, CL; Zhang, S | 1 |
| Cheng, J; Dong, H; Shen, J; Xu, Y; Ye, Q; Zhao, J; Zheng, X; Zhu, S | 1 |
| Cui, L; Feng, L; Jia, XB; Zhang, ZH | 1 |
| Chi, HG; Huang, SG; Lv, RX; Ye, H; Yu, FY; Zhang, HY; Zheng, XB; Zou, Y | 1 |
| Chi, HG; Huang, SG; Lu, RX; Yu, FY; Zhang, HY; Zheng, XB; Zou, Y | 1 |
| Dai, SX; Feng, YL; Liu, HB; Zheng, XB; Zou, Y | 1 |
1 trial(s) available for baicalin and Colitis, Ulcerative
| Article | Year |
|---|---|
[Effect of baicalin on signal transduction and activating transcription factor expression in ulcerative colitis patients].
Topics: Activating Transcription Factors; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Colitis, Ulcerative; Cytokines; Flavonoids; Humans; Interleukin-10; Interleukin-4; Interleukin-6; Irritable Bowel Syndrome; Leukocytes, Mononuclear; Medicine, Chinese Traditional; Phosphorylation; Signal Transduction; STAT6 Transcription Factor | 2015 |
9 other study(ies) available for baicalin and Colitis, Ulcerative
| Article | Year |
|---|---|
Design, synthesis and evaluation of a baicalin and berberine hybrid compound as therapeutic agent for ulcerative colitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bacteria; Berberine; Colitis, Ulcerative; Dextran Sulfate; Dose-Response Relationship, Drug; Drug Design; Flavonoids; Male; Mice; Mice, Inbred BALB C; Molecular Structure; Structure-Activity Relationship; Superoxide Dismutase | 2020 |
A Combination of Baicalin and Berberine Hydrochloride Ameliorates Dextran Sulfate Sodium-Induced Colitis by Modulating Colon Gut Microbiota.
Topics: Animals; Berberine; Colitis; Colitis, Ulcerative; Colon; Cytokines; Dextran Sulfate; Disease Models, Animal; Flavonoids; Gastrointestinal Microbiome; Mice; Mice, Inbred C57BL | 2022 |
Protective effect of baicalin on the regulation of Treg/Th17 balance, gut microbiota and short-chain fatty acids in rats with ulcerative colitis.
Topics: Animals; Butyrates; Colitis, Ulcerative; Disease Models, Animal; Dysbiosis; Fatty Acids, Volatile; Flavonoids; Gastrointestinal Microbiome; Gastrointestinal Tract; Prebiotics; Rats; T-Lymphocytes, Regulatory; Th17 Cells; Trinitrobenzenesulfonic Acid | 2020 |
Synergistic effect of combined treatment with baicalin and emodin on DSS-induced colitis in mouse.
Topics: Animals; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Emodin; Flavonoids; Mice; NF-kappa B | 2021 |
Baicalin may alleviate inflammatory infiltration in dextran sodium sulfate-induced chronic ulcerative colitis via inhibiting IL-33 expression.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Flavonoids; Interleukin-33; Male; Mice, Inbred C57BL; NF-kappa B | 2017 |
Regulating effect of baicalin on IKK/IKB/NF-kB signaling pathway and apoptosis-related proteins in rats with ulcerative colitis.
Topics: Animals; Apoptosis Regulatory Proteins; Colitis, Ulcerative; Colon; Flavonoids; I-kappa B Kinase; Interleukin-1beta; Male; Mice; NF-kappa B; Oxidative Stress; Peroxidase; Rats, Sprague-Dawley; RAW 264.7 Cells; Signal Transduction; Tumor Necrosis Factor-alpha | 2019 |
The anti-inflammation effect of baicalin on experimental colitis through inhibiting TLR4/NF-κB pathway activation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Chemokine CCL2; Colitis, Ulcerative; Colon; Cytokines; Disease Models, Animal; Flavonoids; Humans; Intercellular Adhesion Molecule-1; Male; Mice; NF-kappa B; Rats; Rats, Sprague-Dawley; Signal Transduction; Toll-Like Receptor 4 | 2014 |
Effects of baicalin in CD4 + CD29 + T cell subsets of ulcerative colitis patients.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Biomarkers; Case-Control Studies; Cell Proliferation; Cells, Cultured; Colitis, Ulcerative; Cytokines; Dose-Response Relationship, Drug; Female; Flavonoids; Gene Expression Regulation; Humans; Immunosuppressive Agents; Inflammation Mediators; Integrin beta1; Lymphocyte Activation; Male; Middle Aged; Signal Transduction; T-Lymphocytes, Helper-Inducer; Time Factors; Young Adult | 2014 |
Baicalin down-regulates the expression of macrophage migration inhibitory factor (MIF) effectively for rats with ulcerative colitis.
Topics: Animals; Chemokine CCL2; Chemokine CCL20; Colitis, Ulcerative; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Flavonoids; Immunohistochemistry; Intramolecular Oxidoreductases; Macrophage Migration-Inhibitory Factors; Macrophages; Mesalamine; Rats; Rats, Sprague-Dawley; Trinitrobenzenesulfonic Acid | 2012 |